Beth A. Drzewiecki
Boston Children's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Beth A. Drzewiecki.
The Journal of Urology | 2011
Beth A. Drzewiecki; Stuart B. Bauer
PURPOSE Urodynamic studies in children have been performed with increasing frequency as the techniques, reproducibility and reliability of the testing have been refined in the last quarter century. Children of all ages and with a variety of comorbidities are now often referred for urodynamic testing to evaluate and understand the causes of incontinence and/or persistence of lower urinary tract symptoms, as well as to appropriately define and evaluate treatment regimens. MATERIALS AND METHODS We performed a MEDLINE® search for relevant articles on urinary tract dysfunction, neurogenic bladder and urodynamic studies in the pediatric population. We also included 3 major textbooks that addressed the subject matter. RESULTS We review the current indications for urodynamic studies in children with nonneurogenic and neurogenic bladder dysfunction. We summarize the components and techniques of the current practice of urodynamic studies in the pediatric population, and explain how to identify abnormal results. CONCLUSIONS The use of urodynamic studies in pediatrics has become almost mandatory for the effective management of severe or therapy resistant urinary tract abnormalities. This review may be used as a guideline for the appropriate application of urodynamics in this patient population.
Neurourology and Urodynamics | 2015
Stuart B. Bauer; Rien J.M. Nijman; Beth A. Drzewiecki; Ulla Sillen; Piet Hoebeke
The objective of this document created by the ICCS standardization subcommittee is to provide a uniform guideline on measurement, quality control and documentation of urodynamic studies in children.
The Journal of Urology | 2009
Beth A. Drzewiecki; Pamela R. Kelly; Barbara Marinaccio; Joseph G. Borer; Carlos R. Estrada; Richard S. Lee; Stuart B. Bauer
PURPOSE Biofeedback therapy is a valuable modality in children with dysfunctional voiding. However, it is unclear what factors contribute to the outcome. To define who may or may not benefit from biofeedback therapy we reviewed our experience with this treatment. MATERIALS AND METHODS We retrospectively reviewed the charts of 77 children referred between July 2005 and September 2008 for biofeedback therapy. An MR 20 Synergy trainer (Prometheus Group, Dover, New Hampshire) provided nonanimated and animated biofeedback. Uroflowmetry was performed at the start and end of each session. A total of 67 females and 10 males with a mean age of 9.0 years (range 4.8 to 18.2) comprised the cohort group. The primary referral diagnosis was nonfebrile urinary tract infection in 52 patients (67.5%), daytime and nighttime wetting in 47 (61%), voiding postponement in 14 (18.2%) and daytime incontinence in 10 (13%). Children were categorized by an outcome of success, improvement or failure. Results were analyzed using the chi-square, Fisher exact probability and Student t tests. RESULTS Success, improvement and failure were achieved in 22 (26.8%), 29 (37.7%) and 26 cases (33.7%), respectively. Age and gender were not statistically significant predictors of outcome. A median of 3.0 sessions (range 1 to 8) was administered. Children with 3 or greater sessions were more likely to succeed (p <0.005). The improvement in urinary tract infections was statistically significant (p <0.001). Of 37 children 20 (54%) transformed a staccato voiding pattern to a normal one on uroflowmetry. CONCLUSIONS Biofeedback therapy can be effective in children with dysfunctional voiding and urinary tract infection. Children with a staccato voiding pattern may require a minimum of 3 visits to improve the voiding pattern. Children who complete 3 sessions are more likely to succeed.
Stem Cells International | 2010
Beth A. Drzewiecki; John C. Thomas; Stacy T. Tanaka
Mesenchymal stem cells can be isolated from almost any adult tissue. In this paper we focus on bone marrow-derived mesenchymal stem cells which have captured the interest of researchers since their introduction because of the promising potential of tissue regeneration and repair. They are known for their ability to self-renew and differentiate into diverse lineages while maintaining low immunogenicity. The exact mechanisms behind how these cells work still remain unclear, and there is a continuing shift in the paradigms that support them. There has been extensive research in multiple organ systems; however, the genitorurinary system has been vastly underrepresented. This article discusses the background behind bone marrow-derived mesenchymal stem cells and they are currently being applied to the urinary bladder in the realm of tissue engineering. We also postulate on their future applications based on the current literature in other organ systems.
European urology focus | 2018
Justin A. Lee; Matthew K. Abramowitz; Naama Kipperman; Beth A. Drzewiecki; Michal L. Melamed; Joshua M. Stern
BACKGROUND The prevalence of urinary stone disease (USD) and asthma is rising and has recently been associated in a pediatric population. OBJECTIVE To investigate the association between asthma and USD in a nationally representative adult population. DESIGN, SETTING, AND PARTICIPANTS We analyzed the National Health and Nutrition Examination Survey 2007-2014, a US population-based cross-sectional study. A history of asthma and USD was obtained by self-report to questionnaires. USD severity was represented by graded stratification into non-stone formers, single stone formers, and recurrent stone formers (>2 stones). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS Odds ratios (ORs) for asthma were calculated for respondents with USD and separately for the graded USD groups. Survey-weighted logistic regression models included adjustments for demographics (model A), medical information (model B), and for relevant medications (model C). RESULTS AND LIMITATIONS A total of 20 906 participants aged ≥20 yr were included in the analysis. Of these, 9.2% reported of having a history of kidney stones. Logistic regression analysis adjusted for demographics, medical conditions, and medications showed that stone formers had significantly increased odds of asthma (odds ratio=1.23; 95% confidence interval: 1.03-1.47; p=0.023). Separate logistic regression analysis demonstrated a graded association between single and recurrent stone formers and the odds of having asthma (p=0.01), which remained significant in the 20-50-yr-old population and the diabetic population, especially for recurrent stone formers. Causal relationships were limited by cross-sectional nature of the study. CONCLUSIONS Increasing severity of USD is associated with an increase in odds for asthma among American adults, providing impetus for future studies into the mechanisms explaining this phenomenon. PATIENT SUMMARY In this report, we looked at self-reported histories of asthma and urinary stone disease (USD) using information from a large US population. We found that asthma was associated with USD; however, further studies are needed to elucidate this relationship.
International Braz J Urol | 2018
Ari P. Bernstein; Ethan B. Fram; Amanda North; Anthony Casale; Beth A. Drzewiecki
Pediatric incontinence: Evaluation and clinical management | 2015
Beth A. Drzewiecki; Stuart B. Bauer
Neoreviews | 2014
Danielle Levitt; Jennifer McGuirl; Beth A. Drzewiecki; M. Susan LaTuga
The Journal of Urology | 2012
Beth A. Drzewiecki; Douglass B. Clayton; John C. Thomas; John C. Pope; Mark C. Adams; John W. Brock; Stacy T. Tanaka
The Journal of Urology | 2011
Beth A. Drzewiecki; John C. Thomas; Stacy T. Tanaka; John C. Pope; Mark C. Adams; John W. Brock